%20(2).png){kind=logo}
Inside Chase Feiger's newest Forbes piece, he sits down with Giles Platford, President of the Takeda Plasma-Derived Therapies Business Unit, to discuss the challenges and breakthroughs shaping the future of PDTs.
Ostro, a leader in AI-driven digital engagement solutions, is proud to spotlight its partnership with the Desmoid Tumor Research Foundation (DTRF) as we approach Rare Disease Month, a meaningful time to foster awareness and champion impactful innovation.
AI can transform pharmaceutical marketing by scaling personalized content development and delivery and optimizing processes. But it must be deployed responsibly, with clear guardrails to ensure compliance.
.jpg)
As of October 1, 2024, pharmaceutical companies promoting prescription medicines in the UK must adhere to the revised standards outlined in the new Association of the British Pharmaceutical Industry (ABPI) 2024 Code of Conduct.
In the global fight against HIV, a twice-yearly injection could represent a seismic shift in prevention efforts.
The Healthcare Technology Report has recognized Ostro as one of the Top 100 Healthcare Technology Companies of 2024.
Is time spent on your website a sign of engagement or frustration? For pharma brands, recognizing the difference between productive and non-productive actions is crucial to driving meaningful engagement.
At Ostro, we don’t make new medicines, but we like to say that our talent is making medicine make sense.
The pharma sector faces a critical challenge: bridging the widening digital divide. To keep pace with rapid technological advancements, companies need to break down silos and integrate their digital initiatives, ensuring a seamless and effective approach to innovation.
.svg)